OVID SCHEDULE 13G/A: SEC filing

RA Capital Management and affiliated reporting persons

Filed with the SEC on · accession 0001346824-26-000289

OVID filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -5.5% by the first close after the filing.

Summary of the filing

RA Capital Management and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 15,968,626 shares, or 7.8%, of Ovid Therapeutics common stock as of September 30, 2026, held largely through shares and immediately exercisable warrants.

Key details

Aggregate shares beneficially owned$16.0M
Shares of common stock directly held by the Fund$5.6M
Shares underlying Pre-Funded Warrants$5.0M
Shares underlying Series B Common Warrants$5.4M
Reporting person / investment adviserRA Capital Management, L.P.
Reporting person / direct holder of securitiesRA Capital Healthcare Fund, L.P.
IssuerOvid Therapeutics Inc.
Authorized signatory / managing member of ra capitalPeter Kolchinsky
Authorized signatory / managing member of ra capitalRajeev Shah

How OVID stock reacted

Close before

$2.54

Nov 13, 2026

First close after

-5.51%

$2.40

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for OVID, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for OVID?

Click here

Frequently asked questions

What did OVID file with the SEC on Nov 16, 2026?

OVID filed a SCHEDULE 13G/A (SEC filing). RA Capital Management and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 15,968,626 shares, or 7.8%, of Ovid Therapeutics common stock as of September 30, 2026, held largely through shares and immediately exercisable warrants.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did OVID stock react to this filing?

OVID closed at $2.54 before the filing and $2.40 on Nov 16, 2026 (-5.51%).

Other OVID SEC filings

Get alerts when OVID files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days